Coverage for Medicare’s e-visits still available, though few patients use service
By
Kristen Fischer
Apr 16, 2024
E-visits, which drew expanded coverage during the pandemic still are available but not used often, a new study shows.
Fresh, delivered produce tied to improvements in CVD risk factors
Mar 22, 2024
Significant improvements were seen for produce consumption, physical activity, non-high-density lipoprotein cholesterol and HbA1c.
Telehealth, monitoring tech, make a meaningful difference in helping seniors with hypertension: study
By
Aaron Dorman
Feb 21, 2024
Digital health interventions make a positive impact in managing hypertension among seniors, according to a study released last week.
Lipid-lowering drugs save lives, but use decreasing
Dec 01, 2023
In 2019 to 2020, 56% of patients with high cholesterol were on statins for primary prevention and 85% were on them for secondary prevention.
EPA proposes removing 100 percent of lead pipes from US water system
Nov 30, 2023
Utility companies expected to cover most of the cost, but there is $15 billion available in the 2021 infrastructure law to help
AHA: Fresh produce prescription improves glycemic control
Nov 14, 2023
The findings were seen among low-income individuals with diabetes and poor glycemic control.
High remote patient monitoring practices offer improved hypertension care
Nov 07, 2023
An increase was seen in hypertension medication fills, days’ supply and unique medications received, but an increase in hypertension-linked spending also was seen.
Burden of heart disease considerable for American Indians, Alaska Natives
Sep 26, 2023
Half of the participants reported at least one severe cardiovascular condition; the overall mortality rate was 19.8%.
RPM use grows 300 percent in two years, industry study finds
By
Adam Healy
Aug 22, 2023
Remote patient monitoring (RPM) has grown threefold since the pandemic, a recent study shows.
Incidence of new-onset HTN higher for COVID-19 versus influenza patients
Aug 21, 2023
Hospitalized and nonhospitalized patients with COVID-19 were more likely to develop persistent hypertension than those with influenza.